T1	Outcomes 206 219	genital warts
T2	Outcomes 915 934	in total wart area.
T3	Outcomes 935 954	Wart area reduction
T4	Outcomes 1086 1118	immunotherapy, disease reduction
T5	Outcomes 1488 1516	had > 50% disease reduction.
T6	Outcomes 1517 1530	Prior disease
T7	Outcomes 1651 1668	reduction in mean
T8	Outcomes 1918 1938	of recurrent genital
